Simcha Therapeutics
PrivateLast Round
Series B
Jan 27, 2022
Total Funding Raised
$69.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Simcha Therapeutics operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Series B round in January 2022.
Simcha Therapeutics is a biotechnology company developing cytokine immunotherapies that activate the immune system to combat diseases, especially cancers, through the development of decoy-resistant immunotherapies engineered via directed evolution.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simcha Therapeutics Comparables
Compare Simcha Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bright Peak Therapeutics | 89% | |
| Deka Biosciences | 85% | |
| Synthekine | 85% |
For institutional investors. Book with your work email.
Simcha Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 27, 2022 | ||||
| Series A | Jun 24, 2020 | ||||
| Seed | Jul 5, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Simcha Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed, Series A |
| Logos Capital | Series B |
| ArrowMark Partners | Series B |
| BVF Partners L.P. | Series B |
| Pfizer | Series A |
| Samsara BioCapital | Series B |
| Rock Springs Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 30% MoM, reaching 3.3K.
- Jul 24, 2026
Monthly visitors increased 48% MoM.
For institutional investors. Book with your work email.
Simcha Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Simcha Therapeutics's valuation, stock price, and market status.
Is Simcha Therapeutics a public or private company?
Simcha Therapeutics is a private company.
What is the current stock price of Simcha Therapeutics?
Simcha Therapeutics is a private company, so its shares have no public market price. Caplight tracks Simcha Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Simcha Therapeutics worth (valuation)?
Valuation information for Simcha Therapeutics is not publicly available.
Can I buy Simcha Therapeutics stock?
Simcha Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Simcha Therapeutics's last funding round?
Simcha Therapeutics's most recent funding round was Series B on January 27, 2022.
Who are the main investors in Simcha Therapeutics?
Key investors in Simcha Therapeutics include SR One, HongShan Capital Group (HSG).
Will Simcha Therapeutics IPO soon?
No public IPO plans have been announced for Simcha Therapeutics.
How can I track Simcha Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Simcha Therapeutics's shares on secondary markets.